Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease

Completed · Phase 3

Conditions studied: Graft Versus Host Disease

In brief

RATIONALE: Beclomethasone combined with prednisone may be an effective treatment for graft-versus-host disease caused by stem cell transplantation. It is not yet known if prednisone is more effective with or without beclomethasone in treating gastrointestinal graft-versus-host disease. PURPOSE: Randomized phase III trial to determine the effectiveness of prednisone with or without beclomethasone in treating patients who have graft-versus-host disease afftecting the gastrointestinal system.

Key facts

Study ID

NCT00043147

Run by

Memorial Sloan Kettering Cancer Center

Starts

2002-04-01

Expected to finish

2005-01-01

Last updated by the study team

2013-05-30

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Roswell Park Cancer Institute — Buffalo, New York, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.